37
Growth Score
pts
Heat Score
-8 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
960985
Machavert is a pharmaceutical company developing innovative treatments against cancer
- Jakub Staszak-Jirkovsky: Chief Executive OfficerPast Role: Machavert Pharmaceuticals, Founder and Chief Executive Officer
- Chris Johnson: Senior Analytical Chemist
About the Company
Machavert is creating novel drug substances that will embrace the unique proprieties of nature inspired lipids. Their drug platform offers wide range of drug candidates for oncology treatments.
